TTK Healthcare Ltd has been issued an order by the National Pharmaceutical Pricing Authority (NPPA) withdrawing interest that was earlier charged and issuing a fresh interest calculation. Although the details of the order are not specified, the move is presumably connected with drug pricing regulations. The new order may have a bearing on the financial liabilities of TTK Healthcare and could give some relief regarding interest payments. This move by the NPPA reflects the continuous regulatory watch in the pharma industry and the significance of pricing compliance for businesses such as TTK Healthcare. The company would be required to evaluate the cost implications of this order and might give further updates to shareholders from time to time.
Source: TTK Healthcare Ltd Regulatory Filing, February 25, 2025